MD3987C2 - Use of Diosmine for the treatment of advancing hepatic cirrhosis associated with cardiac insufficiency - Google Patents

Use of Diosmine for the treatment of advancing hepatic cirrhosis associated with cardiac insufficiency

Info

Publication number
MD3987C2
MD3987C2 MDA20090104A MD20090104A MD3987C2 MD 3987 C2 MD3987 C2 MD 3987C2 MD A20090104 A MDA20090104 A MD A20090104A MD 20090104 A MD20090104 A MD 20090104A MD 3987 C2 MD3987 C2 MD 3987C2
Authority
MD
Moldova
Prior art keywords
advancing
treatment
diosmine
cardiac insufficiency
hepatic cirrhosis
Prior art date
Application number
MDA20090104A
Other languages
Romanian (ro)
Russian (ru)
Other versions
MD3987B1 (en
Inventor
Георге АНГЕЛИЧ
Виорел МОРАРУ
Original Assignee
Георге АНГЕЛИЧ
САМОХВАЛОВ Сергей
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Георге АНГЕЛИЧ, САМОХВАЛОВ Сергей filed Critical Георге АНГЕЛИЧ
Priority to MDA20090104A priority Critical patent/MD3987C2/en
Publication of MD3987B1 publication Critical patent/MD3987B1/en
Publication of MD3987C2 publication Critical patent/MD3987C2/en

Links

Abstract

The invention relates to medicine, particularly hepatology and can be used for the treatment of patients with advancing hepatic cirrhosis associated with cardiac insufficiency.Summary of the invention consists in the use of Diosmine for the treatment of advancing hepatic cirrhosis associated with cardiac insufficiency, which is administered per os 600 mg, 1...2 times a day, during 1...3 months.
MDA20090104A 2009-09-03 2009-09-03 Use of Diosmine for the treatment of advancing hepatic cirrhosis associated with cardiac insufficiency MD3987C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MDA20090104A MD3987C2 (en) 2009-09-03 2009-09-03 Use of Diosmine for the treatment of advancing hepatic cirrhosis associated with cardiac insufficiency

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MDA20090104A MD3987C2 (en) 2009-09-03 2009-09-03 Use of Diosmine for the treatment of advancing hepatic cirrhosis associated with cardiac insufficiency

Publications (2)

Publication Number Publication Date
MD3987B1 MD3987B1 (en) 2009-12-31
MD3987C2 true MD3987C2 (en) 2010-07-31

Family

ID=43568856

Family Applications (1)

Application Number Title Priority Date Filing Date
MDA20090104A MD3987C2 (en) 2009-09-03 2009-09-03 Use of Diosmine for the treatment of advancing hepatic cirrhosis associated with cardiac insufficiency

Country Status (1)

Country Link
MD (1) MD3987C2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD4232C1 (en) * 2012-11-08 2014-01-31 Георге АНГЕЛИЧ Medicament based on troxerutin and carbazochrome for the treatment of progressive hepatic cirrhosis associated with heart failure

Citations (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1985003864A1 (en) * 1984-03-01 1985-09-12 Casley Smith John Royle Treatment of high protein oedemas by direct application of benzo-pyrones
CH671021A5 (en) * 1987-05-07 1989-07-31 Espanola Prod Quimicos Prodn. of hydroxy:ethylated diosmin mixts. - useful for treating intoxication
FR2661610A1 (en) * 1990-05-02 1991-11-08 Rhone Poulenc Sante Novel lyophilised form of diosmin and its preparation
FR2668705A1 (en) * 1990-11-06 1992-05-07 Bouchara Sa Novel skin preparations having a phlebotonic action and process for preparing them
EP0541874A1 (en) * 1990-05-11 1993-05-19 Jérôme CORBIERE Compositions containing diosmin
FR2692145A1 (en) * 1992-06-10 1993-12-17 Bellon Labor Sa Roger Topical compsns. having a vascular protecting and veinotonic action - contain diosmin, fatty acid(s), hydrating agent, neutralising agent, gelling agent and opt. stabilisers, preservatives, colours, perfumes, etc.
JPH08301757A (en) * 1995-05-10 1996-11-19 Kureha Chem Ind Co Ltd Hsp47 synthesis suppressing agent
NZ280418A (en) * 1994-11-08 1997-03-24 Adir Diosmin composition; effervescent granule, in tablet or sachet form containing micronised diosmin
CA2287363A1 (en) * 1997-05-13 1998-11-19 Remacle, Jose Use of a pharmaceutical composition for treating and/or preventing ischemia
DE19922287A1 (en) * 1998-05-15 1999-11-25 Coletica Lyon Cosmetic, dermatological, pharmaceutical, dietetic or food compositions, e.g. for improving skin condition, comprise flavonoid esters
JP2000023635A (en) * 1998-07-10 2000-01-25 M P G Kk Granule nutrient auxiliary food
WO2000015237A1 (en) * 1998-09-15 2000-03-23 Korea Research Institute Of Bioscience And Biotechnology Composition containing rutin and quercetin for preventing or treating elevated blood lipid level-related diseases
KR20000019719A (en) * 1998-09-15 2000-04-15 박호군 Composition comprising diosmin for preventing and treating hyperlipidemia and arteriosclerosis
KR20010007625A (en) * 2000-10-06 2001-01-26 박호군 Composition for preventing and treating atherosclerosis and hyperlipidemia, comprising diosmin
KR20010007624A (en) * 2000-10-06 2001-01-26 박호군 Composition for preventing and treating atherosclerosis, hyperlipidemia, hepatic diseases and glycosemia, comprising neohesperidin dihydrochalcone
WO2002020030A2 (en) * 2000-09-11 2002-03-14 Michael D Stander Use of buchu extracts for hypertension
WO2004032942A1 (en) * 2002-10-11 2004-04-22 Laboratoires Innothera Sas Dry oral phlebotonic and vasculoprotective formulation for the treatment of venous insufficiency, capillary fragility and haemorrhoids, in the pharmaceutical form of a chewable tablet containing diosmin
FR2857665A1 (en) * 2003-07-16 2005-01-21 Centre Nat Rech Scient New 3-halo flavone derivatives useful for treating disorders involving an excess of oxidizing species, e.g. cancer, ischemic diseases, dermatosis, neurodegenerative diseases, inflammatory diseases
US20060040911A1 (en) * 2003-01-06 2006-02-23 Liao Benedict S Method for preventing and/or treating the cardiovascular and hepatic diseases induced by hyperlipidemia which comprises administered an effective amount of bioflavonoids extract derived from fructus crataegus (lipid metabolism and fructus crataegus)
CN1823807A (en) * 2006-01-11 2006-08-30 刘展欣 Micronize diosmin and hesperidine composition suppository
EP1707192A2 (en) * 2005-03-30 2006-10-04 Therapicon Srl Pharmaceutical composition
MX2007011002A (en) * 2007-09-07 2009-03-09 World Trade Imp Export Wtie Ag Pharmaceutical composition combining various venotonic and vasoprotective agents for the treatment of chronic venous insufficiency.

Patent Citations (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1985003864A1 (en) * 1984-03-01 1985-09-12 Casley Smith John Royle Treatment of high protein oedemas by direct application of benzo-pyrones
CH671021A5 (en) * 1987-05-07 1989-07-31 Espanola Prod Quimicos Prodn. of hydroxy:ethylated diosmin mixts. - useful for treating intoxication
FR2661610A1 (en) * 1990-05-02 1991-11-08 Rhone Poulenc Sante Novel lyophilised form of diosmin and its preparation
EP0541874A1 (en) * 1990-05-11 1993-05-19 Jérôme CORBIERE Compositions containing diosmin
FR2668705A1 (en) * 1990-11-06 1992-05-07 Bouchara Sa Novel skin preparations having a phlebotonic action and process for preparing them
FR2692145A1 (en) * 1992-06-10 1993-12-17 Bellon Labor Sa Roger Topical compsns. having a vascular protecting and veinotonic action - contain diosmin, fatty acid(s), hydrating agent, neutralising agent, gelling agent and opt. stabilisers, preservatives, colours, perfumes, etc.
FR2692145B1 (en) * 1992-06-10 1995-05-05 Bellon Labor Sa Roger New composition for topical use containing diosmin.
NZ280418A (en) * 1994-11-08 1997-03-24 Adir Diosmin composition; effervescent granule, in tablet or sachet form containing micronised diosmin
JPH08301757A (en) * 1995-05-10 1996-11-19 Kureha Chem Ind Co Ltd Hsp47 synthesis suppressing agent
CA2287363A1 (en) * 1997-05-13 1998-11-19 Remacle, Jose Use of a pharmaceutical composition for treating and/or preventing ischemia
DE19922287A1 (en) * 1998-05-15 1999-11-25 Coletica Lyon Cosmetic, dermatological, pharmaceutical, dietetic or food compositions, e.g. for improving skin condition, comprise flavonoid esters
JP2000023635A (en) * 1998-07-10 2000-01-25 M P G Kk Granule nutrient auxiliary food
WO2000015237A1 (en) * 1998-09-15 2000-03-23 Korea Research Institute Of Bioscience And Biotechnology Composition containing rutin and quercetin for preventing or treating elevated blood lipid level-related diseases
KR20000019719A (en) * 1998-09-15 2000-04-15 박호군 Composition comprising diosmin for preventing and treating hyperlipidemia and arteriosclerosis
WO2002020030A2 (en) * 2000-09-11 2002-03-14 Michael D Stander Use of buchu extracts for hypertension
KR20010007625A (en) * 2000-10-06 2001-01-26 박호군 Composition for preventing and treating atherosclerosis and hyperlipidemia, comprising diosmin
KR20010007624A (en) * 2000-10-06 2001-01-26 박호군 Composition for preventing and treating atherosclerosis, hyperlipidemia, hepatic diseases and glycosemia, comprising neohesperidin dihydrochalcone
WO2004032942A1 (en) * 2002-10-11 2004-04-22 Laboratoires Innothera Sas Dry oral phlebotonic and vasculoprotective formulation for the treatment of venous insufficiency, capillary fragility and haemorrhoids, in the pharmaceutical form of a chewable tablet containing diosmin
US20060040911A1 (en) * 2003-01-06 2006-02-23 Liao Benedict S Method for preventing and/or treating the cardiovascular and hepatic diseases induced by hyperlipidemia which comprises administered an effective amount of bioflavonoids extract derived from fructus crataegus (lipid metabolism and fructus crataegus)
FR2857665A1 (en) * 2003-07-16 2005-01-21 Centre Nat Rech Scient New 3-halo flavone derivatives useful for treating disorders involving an excess of oxidizing species, e.g. cancer, ischemic diseases, dermatosis, neurodegenerative diseases, inflammatory diseases
EP1707192A2 (en) * 2005-03-30 2006-10-04 Therapicon Srl Pharmaceutical composition
CN1823807A (en) * 2006-01-11 2006-08-30 刘展欣 Micronize diosmin and hesperidine composition suppository
MX2007011002A (en) * 2007-09-07 2009-03-09 World Trade Imp Export Wtie Ag Pharmaceutical composition combining various venotonic and vasoprotective agents for the treatment of chronic venous insufficiency.

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Matcovschi C., Procopişin V., Parii B. Compendium medicamentorum. Tipografia Centrală, Chişinău, 2001, p. 759 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD4232C1 (en) * 2012-11-08 2014-01-31 Георге АНГЕЛИЧ Medicament based on troxerutin and carbazochrome for the treatment of progressive hepatic cirrhosis associated with heart failure

Also Published As

Publication number Publication date
MD3987B1 (en) 2009-12-31

Similar Documents

Publication Publication Date Title
IL208992A (en) Use of a pharmaceutically active h2 relaxin in the manufacture of medicaments for treating dyspnea associated with acute heart failure and acute decompensated heart failure
PE20142319A1 (en) MULTIPLE SCLEROSIS TREATMENT WITH A COMBINATION OF LAQUINIMOD AND GLATIRAMER ACETATE
NZ714963A (en) Compositions and methods for treating anemia
MY173215A (en) Acetylcysteine compositions and methods of use thereof
AR086356A1 (en) PHARMACEUTICAL COMBINATION FOR USE IN THE TREATMENT OF PATIENTS WHO HAVE TYPE 2 DIABETES
UA105191C2 (en) Treatment with pirfenidone of patients with abnormal liver function
MX2016011333A (en) Drug delivery systems and methods for treatment of bladder cancer with gemcitabine.
AU2018256619A1 (en) Compounds for the treatment of obesity and methods of use thereof
TNSN08385A1 (en) Delayed-release glucocorticoid treatment of rheumatoid disease
MX2010008433A (en) Use of ranolazine for the treatment of cardiovascular diseases.
NZ588886A (en) Use of dronedarone alone or in combination for preparing a medicament for the treatment of patients with arrhythmia and having an increase of creatinine level
MD3987C2 (en) Use of Diosmine for the treatment of advancing hepatic cirrhosis associated with cardiac insufficiency
NZ604009A (en) A combination composition comprising ibuprofen and paracetamol
MX2018011293A (en) Prolonged release pharmaceutical composition comprising cysteamine or salt thereof.
MD3986C2 (en) Use of Diosmine for the treatment of portal gastropathies in the hepatic cirrhosis
MD4232B1 (en) Medicament based on troxerutin and carbazochrome for the treatment of progressive hepatic cirrhosis associated with heart failure
MD596Y (en) Method for treating the chronic viral hepatitis C
MD4231C1 (en) Medicament based on troxerutin and carbazochrome for the treatment of portal gastropathies in hepatic cirrhosis
UA101141U (en) The method of correction of the dyslipidemia in patients with myocardial infarction in combination with nonalcoholic steatohepatitis
UA33149U (en) Method for treating arrhythmia in patients with minor structural abnormalities of heart
UA37658U (en) Device for thoracocentesis
UA75872U (en) Method for rehabilitation of patients with ischemic heart disease in combination with diabetes mellitus type 2
MD3476F1 (en) Method of treating the essential hypertension associated with pronounced depressions
UA92865C2 (en) Method for treatment of non-hospital pneumony in patients infected with Chlamydophila pneumoniae, at risk of destabilization of ACCOMPANYING ischemic heart desease
UA103788U (en) Method for treatment of acute coronary syndrome without st-segment elevation in patients with ischemic heart disease and metabolic syndrome following percutaneous transluminar coronary angioplasty

Legal Events

Date Code Title Description
FG4A Patent for invention issued
KA4A Patent for invention lapsed due to non-payment of fees (with right of restoration)
MM4A Patent for invention definitely lapsed due to non-payment of fees